Novel tumor-targeting, self-assembling peptide nanofiber as a carrier for effective curcumin delivery

International Journal of Nanomedicine

Volumn 9, Issue 1, 2013, Pages 197-207

  Liu, Jianfeng ^a   Liu, Jinjian ^a   Xu, Hongyan ^a   Zhang, Yumin ^a   Chu, Liping ^a   Liu, Qingfen ^a   Song, Naling ^a   Yang, Cuihong ^a  

^a BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

Curcumin; Drug delivery; Nanofiber; Self assembling; Tumor targeting

Indexed keywords

CURCUMIN; NANOFIBER; PEPTIDE; VITRONECTIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOMA CELL; CELL STRAIN HEPG2; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TUMOR LEVEL; EX VIVO STUDY; HUMAN; HUMAN CELL; HYDROPHOBICITY; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MALE; MOUSE; NANOENCAPSULATION; NANOPHARMACEUTICS; NONHUMAN; PROTEIN ASSEMBLY; PROTEIN STRUCTURE; SUSTAINED RELEASE FORMULATION;

CURCUMIN; DRUG DELIVERY; NANOFIBER; SELF-ASSEMBLING; TUMOR-TARGETING;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CURCUMIN; DIFFUSION; HEP G2 CELLS; HUMANS; MALE; MCF-7 CELLS; MICE; MICE, INBRED BALB C; NANOCAPSULES; NANOFIBERS; NEOPLASMS, EXPERIMENTAL; NIH 3T3 CELLS; OLIGOPEPTIDES; PROTEIN BINDING; TREATMENT OUTCOME;

EID: 84891516163     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S55875     Document Type: Article

References (42)

1. Najer A, Wu D, Vasquez D, Palivan CG, Meier W. Polymer nanocompartments in broad-spectrum medical applications. Nanomedicine (Lond). 2013;8(3):425-447.
2. Bala V, Rao S, Boyd BJ, Prestidge CA. Prodrug and nanomedicine approaches for the delivery of the camptothecin analogue SN38. J Control Release. 2013;172(1):48-61.
3. Das M, Singh RP, Datir SR, Jain S. Intranuclear drug delivery and effective in vivo cancer therapy via estradiol-PEG-appended multiwalled carbon nanotubes. Mol Pharm. August 19, 2013. [Epub ahead of print.]
4. Teow HM, Zhou Z, Najlah M, Yusof SR, Abbott NJ, D'Emanuele A. Delivery of paclitaxel across cellular barriers using a dendrimer-based nanocarrier. Int J Pharm. 2013;441(1-2):701-711.
5. Qi X, Li N, Gu H, et al. Amphiphilic oligomer-based micelles as cisplatin nanocarriers for cancer therapy. Nanoscale. 2013;5(19):8925-8929.
6. Jing X, Deng L, Gao B, et al. A novel polyethylene glycol mediated lipid nanoemulsion as drug delivery carrier for paclitaxel. Nanomedicine. August 20, 2013. [Epub ahead of print.]
7. Yang C, Li D, Liu Z, et al. Responsive small molecular hydrogels based on adamantane-peptides for cell culture. J Phys Chem B. 2012;116(1): 633-638.
8. Nune M, Kumaraswamy P, Krishnan UM, Sethuraman S. Self-assembling peptide nanofibrous scaffolds for tissue engineering: novel approaches and strategies for effective functional regeneration. Curr Protein Pept Sci. 2013;14(1):70-84.
9. Hu Y, Wang H, Wang J, et al. Supramolecular hydrogels inspired by collagen for tissue engineering. Org Biomol Chem. 2010;8(14):3267-3271.
10. Wang H, Wei J, Yang C, et al. The inhibition of tumor growth and metastasis by self-assembled nanofibers of Taxol. Biomaterials. 2012; 33(24):5848-5853.
11. Zhang P, Cheetham AG, Lin YA, Cui H. Self-assembled Tat nanofibers as effective drug carrier and transporter. ACS Nano. 2013;7(7):5965-5977.
12. Soukasene S, Toft DJ, Moyer TJ, et al. Antitumor activity of peptide amphiphile nanofiber-encapsulated camptothecin. ACS Nano. 2011;5(11):9113-9121.
13. Cho H, Indig GL, Weichert J, Shin HC, Kwon GS. In vivo cancer imaging by poly(ethylene glycol)-b-poly(varepsilon-caprolactone) micelles containing a near-infrared probe. Nanomedicine. 2012;8(2): 228-236.
14. Wagh A, Singh J, Qian S, Law B. A short circulating peptide nanofiber as a carrier for tumoral delivery. Nanomedicine. 2013;9(4):449-457.
15. Liu J, Liu J, Chu L, et al. Novel peptide-dendrimer conjugates as drug carriers for targeting nonsmall cell lung cancer. Int J Nanomedicine. 2011;6:59-69.
16. Kim TH, Jo YG, Jiang HH, et al. PEG-transferrin conjugated TRAIL (TNF-related apoptosis-inducing ligand) for therapeutic tumor targeting. J Control Release. 2012;162(2):422-428.
17. Li X, Zhao Q, Qiu L. Smart ligand: Aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy. J Control Release. 2013;171(2):152-162.
18. Li J, Zheng L, Cai H, et al. Polyethyleneimine-mediated synthesis of folic acid-targeted iron oxide nanoparticles for in vivo tumor MR imaging. Biomaterials. 2013;34(33):8382-8392.
19. Yu Z, Schmaltz RM, Bozeman TC, et al. Selective tumor cell targeting by the disaccharide moiety of bleomycin. J Am Chem Soc. 2013;135(8): 2883-2886.
20. Cabodi S, Di Stefano P, Leal MP, et al. Integrins and signal transduction. Adv Exp Med Biol. 2010;674:43-54.
21. Hynes RO. A reevaluation of integrins as regulators of angiogenesis. Nat Med. 2002;8(9):918-921.
22. Chen Z, Deng J, Zhao Y, Tao T. Cyclic RGD peptide-modified liposomal drug delivery system: enhanced cellular uptake in vitro and improved pharmacokinetics in rats. Int J Nanomedicine. 2012;7:3803-3811.
23. Cai LL, Liu P, Li X, et al. RGD peptide-mediated chitosan-based polymeric micelles targeting delivery for integrin-overexpressing tumor cells. Int J Nanomedicine. 2011;6:3499-3508.
24. Zhu S, Qian L, Hong M, Zhang L, Pei Y, Jiang Y. RGD-modified PEG-PAMAM-DOX conjugate: in vitro and in vivo targeting to both tumor neovascular endothelial cells and tumor cells. Adv Mater. 2011;23(12): H84-H89.
25. Fang IJ, Slowing II, Wu KC, Lin VS, Trewyn BG. Ligand conformation dictates membrane and endosomal trafficking of arginine-glycine-aspartate (RGD)-functionalized mesoporous silica nanoparticles. Chemistry. 2012;18(25):7787-7792.
26. Zhu L, Guo N, Li Q, et al. Dynamic PET and optical imaging and compartment modeling using a dual-labeled cyclic RGD peptide probe. Theranostics. 2012;2(8):746-756.
27. Shao G, Zhou Y, Wang F, Liu S. Monitoring glioma growth and tumor necrosis with the U-SPECT-II/CT scanner by targeting integrin αvβ3. Mol Imaging. 2013;12(1):39-48.
28. Zheng S, Huang M, Hong R, et al. RGD-conjugated iron oxide magnetic nanoparticles for magnetic resonance imaging contrast enhancement and hyperthermia. J Biomater Appl. June 24, 2013. [Epub ahead of print.]
29. Lu Y, Zhong Y, Wang J, et al. Aqueous synthesized near-infrared-emitting quantum dots for RGD-based in vivo active tumour targeting. Nanotechnology. 2013;24(13):135-401.
30. Geng Y, Dalhaimer P, Cai S, et al. Shape effects of filaments versus spherical particles in flow and drug delivery. Nat Nanotechnol. 2007; 2(4):249-255.
31. Christian DA, Cai S, Garbuzenko OB, et al. Flexible filaments for in vivo imaging and delivery: persistent circulation of filomicelles opens the dosage window for sustained tumor shrinkage. Mol Pharm. 2009;6(5): 1343-1352.
32. Kunnumakkara AB, Anand P, Aggarwal BB. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett. 2008;269(2):199-225.
33. Yallapu MM, Jaggi M, Chauhan SC. Curcumin nanomedicine: a road to cancer therapeutics. Curr Pharm Des. 2013;19(11):1994-2010.
34. Maheshwari RK, Singh AK, Gaddipati J, Srimal RC. Multiple biological activities of curcumin: a short review. Life Sci. 2006;78(18): 2081-2087.
35. Ranjan AP, Mukerjee A, Helson L, Gupta R, Vishwanatha JK. Efficacy of liposomal curcumin in a human pancreatic tumor xenograft model: inhibition of tumor growth and angiogenesis. Anticancer Res. 2013;33(9):3603-3609.
36. Sun J, Bi C, Chan HM, Sun S, Zhang Q, Zheng Y. Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability. Colloids Surf B Biointerfaces. 2013;111C:367-375.
37. Altunbas A, Lee SJ, Rajasekaran SA, Schneider JP, Pochan DJ. Encapsulation of curcumin in self-assembling peptide hydrogels as injectable drug delivery vehicles. Biomaterials. 2011;32(25): 5906-5914.
38. Xu Q, Liu Y, Su S, et al. Anti-tumor activity of paclitaxel through dual-targeting carrier of cyclic RGD and transferring conjugated hyperbranched copolymer nanoparticles. Biomaterials. 2012;33(5): 1627-1639.
39. Su CL, Wang YT, Chang MH, Fang K, Chen K. The novel heterocyclic trioxirane [(1,3,5-tris oxiran-2-yl)methyl)-1,3,5-triazinane-2,4,6-trione (TATT)] exhibits a better anticancer effect than platinum-based chemotherapy by induction of apoptosis and curcumin further enhances its chemosensitivity. Cell Biochem Biophys. September 28, 2013. [Epub ahead of print.]
40. Gupta S, Jain A, Chakraborty M, Sahni JK, Ali J, Dang S. Oral delivery of therapeutic proteins and peptides: a review on recent developments. Drug Deliv. 2013;20(6):237-246.
41. Bakhru SH, Furtado S, Morello AP, Mathiowitz E. Oral delivery of proteins by biodegradable nanoparticles. Adv Drug Deliv Rev. 2013;65(6):811-821.
42. Longmire M, Choyke PL, Kobayashi H. Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine (Lond). 2008;3(5):703-717.